Alerts will be sent to your verified email
Verify Email
EMMESSA
|
Emmessar Biotech&Nut
|
Link Pharma Chem
|
Parmax Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.99 % | 1.59 % | -1068.03 % |
|
5yr average Equity Multiplier
|
1.23 | 1.99 | 29.23 |
|
5yr Average Asset Turnover Ratio
|
0.25 | 1.33 | 1.05 |
|
5yr Avg Net Profit Margin
|
77.44 % | -0.06 % | -11.29 % |
|
Price to Book
|
1.63 | 0.99 | 0.0 |
|
P/E
|
56.7 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
63.13 Days | 82.44 Days | -92.25 Days |
|
Inventory Days
|
54.75 Days | 64.96 Days | 69.37 Days |
|
Days Receivable
|
11.98 Days | 72.97 Days | 20.01 Days |
|
Days Payable
|
169.78 Days | 84.21 Days | 296.94 Days |
|
5yr Average Interest Coverage Ratio
|
820.35 | 2.35 | -0.77 |
|
5yr Avg ROCE
|
17.27 % | 5.35 % | -14.3 % |
|
5yr Avg Operating Profit Margin
|
-130.11 % | 3.76 % | 2.43 % |
|
5 yr average Debt to Equity
|
0.0 | 0.49 | 10.96 |
|
5yr CAGR Net Profit
|
-26.08 % | n/a | n/a |
|
5yr Average Return on Assets
|
8.75 % | 0.6 % | -9.05 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.53 % | 51.49 % | 30.8 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.0 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Emmessar Biotech&Nut
|
Link Pharma Chem
|
Parmax Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|